Fed. Circ. Vacates Elan's Win In Classen Patent Suit
The Federal Circuit on Wednesday vacated a lower court's finding that Elan Pharmaceuticals Inc. had not infringed a patent for drug analysis held by Classen Immunotherapies Inc., remanding the matter for...To view the full article, register now.
Already a subscriber? Click here to view full article